Triclosan: release from transdermal adhesive formulations and in vitro permeation across human epidermal membranes
- 23 February 2002
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 235 (1-2) , 229-236
- https://doi.org/10.1016/s0378-5173(01)00992-9
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- BOOK REVIEWSEconomic Analysis and Policy, 2009
- New agents to combat malaria.Nature Medicine, 2001
- Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparumNature Medicine, 2001
- Percutaneous penetration and dermal metabolism of triclosan (2,4,4′-trichloro-2′-hydroxydiphenyl ether)Food and Chemical Toxicology, 2000
- In vitro dermal and transdermal delivery of doxycycline from ethanol/migliol 840 vehicles.International Journal of Pharmaceutics, 1999
- Characterization of Pseudomonas aeruginosa Enoyl-Acyl Carrier Protein Reductase (FabI): a Target for the Antimicrobial Triclosan and Its Role in Acylated Homoserine Lactone SynthesisJournal of Bacteriology, 1999
- Triclosan: Applications and safetyAmerican Journal of Infection Control, 1996